BMR ~131o-lvleccai Kesearcn Ltd.



Similar documents
JUN 2 6 butt. EkoSonicTM Endovascular System with Rapid Pulse Modulation

kok1 UQ 510(k)J Device {Applicant 510(k) Summary (per 21 CFR (c)) OCT Applicant

510(K) SUMMARY. 510(k) Number KOS'00-r

October 28, Cavex Holland Bv Mr. Richard Woortman Manager Technical Services Fustweg 5 Haarlem, 2031CJ The NETHERLANDS

SUMMARY OF SAFETY AND EFFECTIVENESS for Powered Muscle Stimulator

510(k) SUMMARY MANI Needle and Suture Pack MANI, Inc.

May 7, Tactile Systems Technology Inc Daniel Chase V.P. Engineering & Operations 1331 Tyler St NE Minneapolis, Minnesota 55413

AW Server 510 (k) Summary of Safety and Effectiveness

February 5, Dear Kristin Pabst,

Ultimate Concepts Inc.

SECTION 5 BARDEX TEMPERATURE-SENSING FOLEY CATHETER 510(k) SUMMARY OF SAFETY AND EFFECTIVENESS INFORMATION

GE Healthcare MAR

51O(K) SUMMARY: Therapy family of devices.

August 12, Oertli Instrumente AG Ms. Karin Rohr Head of Quality Management & Regulatory Affairs Hafnerwisenstrasse 4 CH 9442 Berneck Switzerland

510(k) Summary of Safety and Effectiveness JUN Hip prosthesis

Q(K SVJM~jPagelIof 3

January 12, Dear Amy Yang:

February 22, Life Spine, Incorporated Mr. Randy Lewis General Manager 2401 West Hassell Road, Suite 1535 Hoffman Estates, Illinois 60169

MViAKIO. V.A hn2 ATTACHMENT I 610(K) SUMMARY. Submitter:

MAY SECTION VIII. 510(k) SUMMARY OF SAFETY AND EFFECTIVENESS

0 EC V-,) 133 Lj9a

(k)Suminary k

L~l t l V~! MAY ?

Simpler Implant Solutions Inc Arbutus St. Vancouver, BC V6i 3Y9. haroldbergmanl~ogmail.com Telephone Fax K080115

Building 6, Suite 300 RyeBrook, NY C-ontact-N~ame: --- William H-. Schofield Director of TeleHealth Operations. Signal,_Radiofrequency

ATLANTIS Anterior Cervical Plate System ATLANTIS Translational Plate. 510(k) Summary. February 2007

March 3, Dear Ms. Alice Gong,

July 24, Dear Ms. Rhodes:

sbchoi~kku.edu jeremy~sooil.com DANA Diabecare IlS Insulin Infusion pump Infusion pump Class II

DEC The three components of the Axxent Electronic Brachytherapy System include the Controller, Balloon Applicators-BR and X-ray Source.

EM GR.OUF DIPLOMAT. OT39?1 Company Name: (K)SUMMARY Oc. Submission Correspondent. Emergo Group, Inc. Company Address:

510(k) Summary. Dentsply Implants. April 30, 2013

510(K) SUMMARY [as required by section (c)] FLIGHT 60 Ventilator 510(k) Number K IaO?2Z, JUL

Ad-tech Medical Instrument Corporation. Principal Consultant Quality & Regulatory Associates, LLC. 800 Levanger Lane. Stoughton, Wisconsin 53589

November 20, Vascular Flow Technologies Ltd. Edwin Lindsay VP of QA/RA Prospect Business Centre, Gemini Cresent Dundee DD2 1TY United Kingdom

510(k) Summary (c)

510(k) SUMMARY APR Date: 15 th December 2008

March 20, Dear Mr. Chen:

August 21, TCM Associates Ltd Mr. Iain Alligan Technical Director 3 Hillgrove Business Park Nazeing Road Essex EN9 2HB United Kingdom

May 5, Dear Mr. Courtney:

MAR (k) SUMMARY OF SAFETY AND EFFECTIVENESS (21CFR ) 1. DATE PREPARED: 4/21/2008

Brainreader ApS February 4, 2015 C/O Mette Munch QA Consultant Skagenvej 21 Egaa, 8250 DENMARK

June 9, Stryker Corporation Garry T. Hayeck, Ph.D. Senior Regulatory Affairs Specialist 2 Pearl Court Allendale, New Jersey 07401

Section 5-510(k) Summary. This document is provided in the following pages. DEC

Datrix, Inc NOV Appendix G. 510(k) Summary of Safety and Effectiveness for Datrix, Inc CardioServer ECG Management System

University of Texas Medical School at Houston. April 14, 2015

Manufacturing Technology, Inc.

2. Contact Person: Garo Mimaryan, MS., RAC 7 Technical Regulatory Affairs Specialist III 3. Phone Number: (914)

,11 DSA Cable, transducer and VS3, VS4 electrode, patient connector

Lewis Ward L.W. Ward and Associates, Inc Kirkwood Court Boulder, CO

foq8 510(k) Summary fo r PAIRIETEX ~ COMPOSITE Mesh

Koqo8 go. ER35 ERO-SCAN Pro Hearing Test System. 61 Martin Lane Elk Grove Village, IL Manager of Instrumentation Products

Phoenix Thera-Lase Systems, LLC Ms. Diane Rutherford Ken Block Consulting 1201 Richardson Drive, Suite 280 Richardson, Texas 75080

JN (k) Summary Device Identification: Device Description:

Fresenius Medical Care

RAMSOFT BUG ,-. I"-, --I 2 N Tel: (416) Fax: (416) sales@ramsoftbiz (k) Summary

April 7, Acclarent, Inc. Mr. James Patrick Garvey II Sr. Manager, Regulatory Affairs 1525-B O'Brien Drive Menlo Park, CA 94025

Dental Morelli Ltda.

DICOM Grid, Inc. January 25, Senior Consultant Biologics Consulting Group, Inc. 400 N. Washington Street, Suite 100 ALEXANDRIA VA 22314

510(k) Summary. Atlanti STM Abutment and AtlantisTM Crown Abutment in Zirconia for Dentsply Ankylos Implant

D I Z1. 510(k) Summary. Section 5. Siemens Medical Solutions USA, Inc. Oncology Care Systems. Date Prepared: September 09,

November 17, Nanova Biomaterials, Inc. Mr. Andrew Ritts Senior Research Scientist 3806 Mojave Ct Columbia, Missouri, 65202

DEC V,(9/azO (c 0 j

May 22, Rachel s Remedies, LLC Mrs. Rachel E. Jackson 2316 Delaware Ave. #174 Buffalo, New York 14216

September 25, Dear Ms. McCoy:

ItP. Section I. 510(k) Summary of Safety and Effectiveness. Applicant:

510(k) Summary GlobalMedia Group, LIC. MAY CONiM

OCT 18 20U5Ibko. a. Submitter Name: Cosmetic Dental Materials Inc. (CDM Inc.) b. Submitter Address: 812 Water St. NE Albany OR 97321

510(k) SUMMARY. OPTION-vyM Urinary Catheter

Ni Hau Industrial Co., Ltd. Ms. Lyn Chiu Sales Manager No. 15, Alley 125, Lane 318, Section 2, An Ho Road Tainan City, Taiwan 70967

October 29, Dear Ms. Hartnett:

ELASTO-GEL MANIJKAH"O"NEY JUUjj 2. fudbthsarltvl of the wound fluid, while re~leas'ing

KIZ 2,33-3 p8 ~ 510(k) Summary. As required by 21 CFR (c) 510(k) Premarket Notification Submission AFrame Digital MobileCare Monitor.

AgaMatrucx. NV2 21 Salem, NH oz (k) Sumnmary

510(K) Summary K102148

March 23, Vision Quest Industries, Inc. Mr. Mohammed Ouerghi Director of QA/RA 1390 Decision Street, Suite A Vista, CA 92081

Dear Ms. Lucas: This letter corrects our substantially equivalent letter of February 18, 2016.

Food and Drug Administration 5 10(k) Notijfication - Partial & Total Ossicular Replacement Prostheses AUG I June 30, 2006

July 21, Dentca, Inc. c/o Mr. Claude Berthoin Denterprise International, Inc. 110 East Granada Blvd, Suite 207 Ormond Beach, Florida 32176

March 31, Etiometry, Inc. Richard Galgon Independent Consulting Associate Quintiles 5846 Cobblestone Lane Waunakee, Wisconsin 53597

May 20, Ivoclar Vivadent Ag Ms. Donna Hartnett Director Regulatory Affairs Ivoclar Vivadent, Inc. 175 Pineview Drive Amherst, New York 14228

Summary of Safety and Effectiveness

MAY Attachment (k) Summary 21 CER

510(k) SUMMARY JUL Otoharmonics 0 Levo 9 System

I C 5 5l v ri 510(K) SUMMARY. Prowess Panther

r5 73~ 9/ / 510(K) Summary (K) SUMMARY

Section (K) Summary. Kimberly-Clark Corporation Winchester Road Neenah, WI 54956

510(k) Summary. (508) X222 Disposable Insulin Delivery Device

smith sm e 0L Zw.. bringing technology to life

510(k) Summary Special Premarket Notification 510(k) Section 6

510(K) SUMMARY FEB Submitter: Name of the device: * Common Name: Clinical Chemistry Analyzer (with optional ISE Module) Attachment #2

Transcription:

BMR ~131o-lvleccai Kesearcn Ltd. Parkmnore Business Park West, Galway, Ireland Tel: +353 (0)91 774300 - Fax: +353 (0)91 774301 6 4& This summary is being submitted in accordance with the requirements of 21 CFR 807.92. 1. Contact Details MAR 1 12009 Name: Address: Anne-Marie Keenan Bio-Medical Research Ltd., Parkmore Business Park, West Galway, Ireland Telephone: +353 91 774300 Fax: +353 91 774301 E-Mail: akeenanp~bmr. ie Prepared: 2 9 th July 2008 Revised: 18th February 2009 2. Device Name Name of Device: Type Number: Proposed Regulatory Class: Baxolve XP Conductive Garment Accessory & Lumbar Support Kit 297 & 298 (Lumbar Support only) Class II (Class I for Lumbar Support Device) Regulation Decritpion ; :n:re : mber e ProductCodes Transcutaneous Electrical Nerve Stimulator for Pain 21 CFR 882.5890 GZJ Relief Truncal Orthosis 21 CFR 890.3490 IQE Cutaneous Electrode 21 CFR 882.1320 GXY 3. Identification of Equivalent Legally Marketed Device 1. Name: Neurotech Baxolve, Manufacturer: 510(k) No: Bio-Medical Research Ltd K023913 2. Name Ultrastim Kit Manufacturer: 510(k) No: Axelgaard Mfg. Co. Ltd. K013532 Directors: T. Kirwan (Chairman), Dr. P. A. Smith (Managing), P.K. McDonnell, C. Minogue, P. McGrath. Registered in Ireland No. 152947

4. Description of Device The Baxolve XP Conductive Garment Accessory and Lumbar Support Kit (Types 297 and 298) is an innovative and comfortable to wear lumbar support belt. It is intended to help relieve lower back pain. The belt is supplied with a detachable sacral pad ("pelotte") that is covered with a stretch towel cover and can be attached to the inside of the belt. For additional comfort, this pelotte includes an array of flexible rubber fingers that ensure the compressive force and it can accommodate movement during walking. The belt may be used simply as a lumbar support device and can provide an adjustable degree of compression to the lumbo-sacral region due to the elasticated nature of the belt itself. To optimize support in the lumbar spine area, Baxolve XP incorporates "Duopress", an easy to adjust twin compression belt system. Compression may be increased with the optional detachable external compression straps. The type 297 version of the Baxolve XP garment may be connected to transcutaneous Electrical Nerve Stimulation (TENS) devices manufactured by Bio-Medical Research Ltd. and is supplied with a pack of four adhesive pads, four electrode stud covers and instructions for use. The type 298 Baxolve XP garment is similar to the type 297 garment except it is intended as a stand-alone lumbar support device. For purposes of hygiene, the Baxolve XP garment may be cleaned and instructions for device care are included in the user manual. 5. Statement of Intended Use/Indications for Use The Baxolve XP Conductive Garment Accessory and Lumbar Support Kit (type 297) can be used with a FDA cleared TENS device, manufactured by Bio-Medical Research Ltd., or alternatively on it's own as a stand-alone lumbar support device. A separate version (type 298) is also available for use as a stand-alone lumbar support device. These devices are for prescription use only. Type 297 (a) Can be used on its own as a lumbar support device or as a conductive garment for use with cleared Transcutaneous Electrical Nerve Stimulation (TENS) devices for the following: Page 2 of 3

The symptomatic relief and management of chronic and intractable pain in the lower back region. * Assists in correctly positioning and repositioning pads on difficult to reach locations of the lower back * Lumbar support Type 298: Can be used on its own as a lumbar support device only: 6. Technological Characteristics There are no technological characteristics in the Baxolve XP Conductive Garment Accessory and Lumbar Support Kit that could affect either the safety or effectiveness of the devices. 7. Clinical and Non-Clinical Tests Bio-Medical Research Ltd. complies with 21 CFR 820 Medical Device Quality System Regulations and also I.S. EN ISO 13485:2003 Medical devices - Quality management systems - Requirements for regulatory purposes (ISO 13485:2003) The Baxolve XP Conductive Garment Accessory and Lumbar Support Kit comply with EN ISO 14971:2007 Medical devices - Application of risk management to medical devices (ISO 14971:2007). Baxolve XP Conductive Garment Accessory and Lumbar Support Kit has also been CE marked under the Medical Device Directive 93/42/EEC. No clinical studies have been submitted as part of this premarket notification. Page 3 of 3

DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Bio-Medical Research, Ltd. % Ms. Anne-Marie Keenan Quality/Regulatory Affairs Engineer Parkmore Business Park, West Galway, Ireland Food and Drug Administration 9200 Corporate Boulevard MAR I11 2009 Rockville MD 20850 Re: K082190 Trade/Device Names: Baxolve XP Conductive Garment Accessory & Lumbar Support Kit, Types 297 & 298 Regulation Number: 21 CFR 882.5890 Regulation Name: Transcutaneous electrical nerve stimulator for pain relief Regulatory Class: II Product Code: GZJ, IQE, GXY Dated: February 18, 2009 Received: February 20, 2009 Dear Ms. Keenan: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may,-therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 - Ms. Anne-Marie Keenan This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at (240) 276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at (240) 276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at toll-free number (800) 638-2041 or (240) 276-3150 or the Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely yours, Enclosure Dk/ctor Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Indications for Use 510(k) Number (if known): Device Name: Baxolve XP Conductive Garment Accessory & Lumbar Support Kit, Types 297 & 298 Indications for Use: Type 297 Can be used on its own as a lumbar support device or as a conductive garment for use 'with cleared Transcutaneous Electrical Nerve Stimulation (TENS) devices for the following: * The symptomatic relief and management of chronic and intractable pain in the lower back region. - Assists in correctly positioning and repositioning pads on difficult to reach locations of the lower back * Lumbar support Type 298 Can be used on its own as a lumbar support device only: Prescription Use X Over-The-Counter Use AND/OR (Part 21 CFR 801 Subpart D) (21 CFR 801 Subpart C) (please DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED) Concurrence of CDRH, Office 9fg j / vision of General, Restov:tive, "..~ Neurological DiBces